MVA-Brachyury-TRICOM

Modified Vaccinia Ankara-based vaccine expressing brachyury and T-cell costimulatory molecules · National Cancer Institute (NCI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA-Brachyury-TRICOM, covering 2021-01-26 to 2021-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]

See pricing